Cargando…
Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665198/ http://dx.doi.org/10.1182/blood-2022-169559 |
| _version_ | 1784831237227020288 |
|---|---|
| author | Fillmore, Nathanael R La, Jennifer Wu, Julie Tsu-Yu Branch-Elliman, Westyn Monach, Paul Brophy, Mary Do, Nhan V Munshi, Nikhil C |
| author_facet | Fillmore, Nathanael R La, Jennifer Wu, Julie Tsu-Yu Branch-Elliman, Westyn Monach, Paul Brophy, Mary Do, Nhan V Munshi, Nikhil C |
| author_sort | Fillmore, Nathanael R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665198 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96651982022-11-16 Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study Fillmore, Nathanael R La, Jennifer Wu, Julie Tsu-Yu Branch-Elliman, Westyn Monach, Paul Brophy, Mary Do, Nhan V Munshi, Nikhil C Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665198/ http://dx.doi.org/10.1182/blood-2022-169559 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Fillmore, Nathanael R La, Jennifer Wu, Julie Tsu-Yu Branch-Elliman, Westyn Monach, Paul Brophy, Mary Do, Nhan V Munshi, Nikhil C Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title | Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title_full | Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title_fullStr | Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title_full_unstemmed | Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title_short | Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study |
| title_sort | increased covid-19 breakthrough infection risk after sars-cov-2 vaccine boosting in patients with plasma cell disorders: a large nationwide veterans affairs study |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665198/ http://dx.doi.org/10.1182/blood-2022-169559 |
| work_keys_str_mv | AT fillmorenathanaelr increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT lajennifer increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT wujulietsuyu increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT branchellimanwestyn increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT monachpaul increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT brophymary increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT donhanv increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy AT munshinikhilc increasedcovid19breakthroughinfectionriskaftersarscov2vaccineboostinginpatientswithplasmacelldisordersalargenationwideveteransaffairsstudy |